you are being redirected

You will be redirected to the website of our parent company, Schönherr Rechtsanwälte GmbH: www.schoenherr.eu

22 April 2021
press release
austria

Austria: Schoenherr again crowned "Austria Law Firm of the Year" by Chambers

For the third time in a row Schoenherr has been awarded the title "Austria Law Firm of the Year" by renowned legal publisher 'Chambers and Partners'.

The winners were announced on 22 April in a digital ceremony and Schoenherr managing partner Michael Lagler remotely accepted the award on behalf of the Austrian office.

"Receiving this award for the third year in a row is true recognition of great team effort and exceptional commitment. I am not only congratulating the Austrian teams today, but all lawyers across our 15 Schoenherr offices who play an important role in positioning us as top go-to-law firm in Central and Eastern Europe. Being named Austrian Law Firm of the Year reflects our expertise and professionalism across the board", managing partner Michael Lagler said. "We know that without our clients and their continued confidence in us we wouldn't be able to celebrate this award today – thank you for your trust, especially during the last challenging year."

In the past year Schoenherr has successfully advised on a significant number of headline deals covering various legal areas as well as jurisdictions. Headline deals in Austria included advising Uniqa on its EUR 1 billion acquisition (and acquisition financing) of AXA assets in CEE; Verbund on the EUR 430 million acquisition of 51% in Gas Connect Austria; the lenders on the EUR 300 million Austrian Airlines rescue financing; the majority shareholders of BIA Separations on the EUR 360 million sale to Sartorius Stedim Biotech; Austrian start-up Bitpanda on the implementation of an investment in the amount of EUR 143 million that led to Bitpanda becoming Austria's first unicorn; S IMMO AG on its acquisition of "Zagrebtower" office complex from CA Immo; and leading AOP Orphan Pharmaceuticals AG (Austria) to victory in arbitration against PharmaEssentia Corporation (Taiwan). All information about these and other deals can be found at www.schoenherr.eu.

Michael
Lagler

Partner

austria vienna